Stonehage Fleming Financial Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$87.6K Sell
73
-1,290
-95% -$1.32M ﹤0.01% 163
2026
Q1
$1.25M Hold
1,363
– – 0.05% 63
2025
Q4
$1.46M Hold
1,363
– – 0.05% 50
2025
Q3
$1.04M Buy
1,363
+50
+4% +$37.2K 0.03% 63
2025
Q2
$1.02M Hold
1,313
– – 0.03% 61
2025
Q1
$1.08M Hold
1,313
– – 0.04% 49
2024
Q4
$1.01M Buy
1,313
+175
+15% +$145K 0.03% 57
2024
Q3
$1.01M Buy
1,138
+963
+550% +$866K 0.03% 58
2024
Q2
$158K Buy
+175
New +$140K ﹤0.01% 137

Other funds holding LLY

Stonehage Fleming Financial Services's LLY Position: Q2 2026 in Review

Stonehage Fleming Financial Services reduced its Eli Lilly (LLY) stake by 95% in Q2 2026, selling an estimated $1.32M and leaving 73 shares worth $87.6K. The position accounts for ﹤0.01% of the portfolio, ranked #163.

Stonehage Fleming Financial Services first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.46M in Q4 2025. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Stonehage Fleming Financial Services held 73 shares of Eli Lilly worth $87.6K as of Q2 2026.
  • Stonehage Fleming Financial Services sold 1,290 Eli Lilly shares in Q2 2026, an estimated $1.32M.
  • Eli Lilly made up ﹤0.01% of Stonehage Fleming Financial Services's portfolio in Q2 2026, its #163 holding.
  • Stonehage Fleming Financial Services first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
  • Stonehage Fleming Financial Services's Eli Lilly position peaked at $1.46M in Q4 2025.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Stonehage Fleming Financial Services's 13F filing for Q2 2026, filed 17 Aug 2026.